Rapid COVID-19 Prognostic Blood Test for Disease Severity Using Epigenetic Immune System Biomarkers

OBJECTIVE: To develop a novel whole-blood epigenetic biomarker of immune system status, or EpiMarker, that would indicate whether a person with a recent COVID-19 diagnosis is at risk for severe symptoms including Acute Respiratory Distress Syndrome. METHODS: Using a novel methyl-sensitive restrictio...

Descripción completa

Detalles Bibliográficos
Autores principales: Marsh, Adam G., Anderson, G. Mark, Izdepski, Erich J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Delaware Academy of Medicine / Delaware Public Health Association 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389811/
https://www.ncbi.nlm.nih.gov/pubmed/34467104
http://dx.doi.org/10.32481/djph.2020.07.08

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389811/
https://www.ncbi.nlm.nih.gov/pubmed/34467104
http://dx.doi.org/10.32481/djph.2020.07.08

Ejemplares similares